rabbit polyclonal antibody against c myc (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
96
Structured Review
Cell Signaling Technology Inc
rabbit polyclonal antibody against c myc
Rabbit Polyclonal Antibody Against C Myc, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 3126 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+c+myc/c-Myc+Antibody/pm39675534-74-0-8
Average 96 stars, based on 3126 article reviews
Rabbit Polyclonal Antibody Against C Myc, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 3126 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rabbit+polyclonal+antibody+against+c+myc/c-Myc+Antibody/pm39675534-74-0-8
Average 96 stars, based on 3126 article reviews
rabbit polyclonal antibody against c myc - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
other:Article Title: Enhanced antitumor immunity in breast cancer: Synergistic effects of ADAM10/ADAM17 inhibition, metabolic modulation, and camptothecin-loaded selenium nanoparticles. Article Snippet: Background: In this study, we investigate the impact of a multi-targeted therapeutic approach that includes camptothecin (CPT), a potent chemotherapeutic topoisomerase inhibitor; metformin (Met), a metabolic modulator with emerging anti-tumor effects; and GW280264X, an inhibitor of ADAM 10/ADAM 17 enzymes, which are associated with tumor invasion and immune response.. The study aims to assess the combined effects of these agents in enhancing CD8 T cell-mediated anti-tumor immunity and suppressing cancer cell growth in triplenegative breast cancer (TNBC) models, both in vitro and in vivo.. Methods: Cell viability was performed on the 4 T1 human TNBC cell line. |